The ergothioneine enigma: Navigating the chasm between anti-aging hype and clinical validation
-
ABSTRACT
Ergothioneine (EGT) has garnered widespread attention due to its purported antioxidant and anti-aging effects, even sparking considerable debate. However, its clinical translation remains hindered by insufficient and fragmented evidence. This article focuses on EGT’s newly identified molecular targets—MPST and CSE—and the indirect regulatory mechanisms mediated by hydrogen sulfide (H2S), thereby exploring key challenges in its clinical application. We highlight major issues in pharmacokinetics, formulation development, and long-term safety, and advocate for interdisciplinary efforts and target-driven clinical evaluation strategies to advance EGT from a cosmetic additive and dietary supplement to a mechanism-based therapeutic agent with a solid scientific foundation. -
-
REFERENCES
[1] Chen L., Zhang L., Ye X., et al. (2023). Ergothioneine and its congeners: Anti-ageing mechanisms and pharmacophore biosynthesis. Protein Cell 15:191−206. DOI:10.1093/procel/pwad048 [2] Cheah I. K. and Halliwell B. (2012). Ergothioneine; antioxidant potential, physiological function and role in disease. Biochim. Biophys. Acta 1822:784−793. DOI:10.1016/j.bbadis.2011.09.017 [3] Yau Y. F., Cheah I. K., Mahendran R., et al. (2024). Investigating the efficacy of ergothioneine to delay cognitive decline in mild cognitively impaired subjects: A pilot study. J. Alzheimers Dis. 102:841−854. DOI:10.1177/13872877241291253 [4] Sprenger H. G., Mittenbühler M. J., Sun Y., et al. (2025). Ergothioneine controls mitochondrial function and exercise performance via direct activation of MPST. Cell Metab. 37:857−869.e9. DOI:10.1016/j.cmet.2025.01.024 [5] Petrovic D., Slade L., Paikopoulos Y., et al. (2025). Ergothioneine improves healthspan of aged animals by enhancing cGPDH activity through CSE-dependent persulfidation. Cell Metab. 37:542−556.e14. DOI:10.1016/j.cmet.2024.12.008 [6] Wen T., Chen W., Wang F., et al. (2025). The roles and functions of ergothioneine in metabolic diseases. J. Nutr. Biochem. 141:109895. DOI:10.1016/j.jnutbio.2025.109895 [7] Chubanava S., Karavaeva I., Ehrlich A. M., et al. (2025). NAD depletion in skeletal muscle does not compromise muscle function or accelerate aging. Cell Metab. 37:1460−1481.e17. DOI:10.1016/j.cmet.2025.04.002 [8] Damgaard M. V. and Treebak J. T. (2023). What is really known about the effects of nicotinamide riboside supplementation in humans. Sci. Adv. 9:eadi4862. DOI:10.1126/sciadv.adi4862 [9] Zhang H., Liu Z., Wang Z., et al. (2025). A review of novel antioxidant ergothioneine: Biosynthesis pathways, production, function and food applications. Foods 14:1588. DOI:10.3390/foods14091588 [10] Li N., Wang S., Li H., et al. (2025). Gut microbiota-driven metabolic alterations reveal the gut-brain communication of ergothioneine in ameliorating cognitive impairment in APP/PS1 mice. J. Agric. Food Chem. 9:16933−16948. DOI:10.1021/acs.jafc.5c02557 -
ABOUT THIS ARTICLE
Cite this article:
Tong Q., Zhao Z., Zhou Y., et al. (2025). The ergothioneine enigma: Navigating the chasm between anti-aging hype and clinical validation. The Innovation Medicine 3:100160. https://doi.org/10.59717/j.xinn-med.2025.100160
Welcome!
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.
Export File
Citation
Tong Q., Zhao Z., Zhou Y., et al. (2025). The ergothioneine enigma: Navigating the chasm between anti-aging hype and clinical validation. The Innovation Medicine 3:100160. https://doi.org/10.59717/j.xinn-med.2025.100160
Format
Content
DownLoad:
-
Figure 1.
Mechanisms and translational challenges of ergothioneine
